Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Natural Resource Partners LP Unit | NRP | May 31, 2024 | 90.35 | +0.70 |
Nature Wood Group ADR | NWGL | May 31, 2024 | 2.26 | +0.89 |
Natures Miracle Holding | NMHI | May 31, 2024 | 0.72 | 0.00 |
Natures Sunshine Products | NATR | May 31, 2024 | 15.32 | +1.06 |
Natuzzi ADR | NTZ | May 31, 2024 | 5.20 | -1.89 |
NatWest ADR | NWG | May 31, 2024 | 8.26 | +0.73 |
Nauticus Robotics | KITT | May 31, 2024 | 0.14 | -0.80 |
Nautilus Biotechnology | NAUT | May 31, 2024 | 2.74 | +3.79 |
Navidea Biopharmaceuticals | NAVB | May 31, 2024 | 0.00 | 0.00 |
Navient | NAVI | May 31, 2024 | 15.07 | -0.33 |
Navigator Holdings | NVGS | May 31, 2024 | 17.49 | -0.79 |
Navios Maritime Partners LP Unit | NMM | May 31, 2024 | 49.43 | +1.85 |
Navitas Semiconductor | NVTS | May 31, 2024 | 3.91 | -1.01 |
Nayax | NYAX | May 31, 2024 | 25.97 | 0.00 |
NB Bancorp | NBBK | May 31, 2024 | 15.12 | +0.80 |
NBT Bancorp | NBTB | May 31, 2024 | 37.18 | +1.28 |
Ncino | NCNO | May 31, 2024 | 30.53 | +1.39 |
NCR | VYX | May 31, 2024 | 13.18 | +1.00 |
NCR Atleos When Issued | NATL | May 31, 2024 | 27.83 | +0.29 |
NCS Multistage | NCSM | May 31, 2024 | 18.02 | 0.00 |
Nektar Therapeutics | NKTR | May 31, 2024 | 1.27 | +0.79 |
Nelnet | NNI | May 31, 2024 | 103.66 | -0.55 |
Neogen | NEOG | May 31, 2024 | 13.15 | -0.30 |
NeoGenomics | NEO | May 31, 2024 | 13.71 | -2.07 |
Neonode | NEON | May 31, 2024 | 3.19 | +7.05 |
NeoVolta | NEOV | May 31, 2024 | 2.52 | -2.70 |
Nephros | NEPH | May 31, 2024 | 2.18 | -0.91 |
NerdWallet A | NRDS | May 31, 2024 | 13.95 | -0.71 |
Nerdy A | NRDY | May 31, 2024 | 1.71 | +1.18 |
Net Lease Office Properties When Issued | NLOP | May 31, 2024 | 23.74 | +3.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.